X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
arginine - analogs & derivatives (388) 388
humans (375) 375
asymmetric dimethylarginine (329) 329
index medicus (319) 319
dimethylaminohydrolase (302) 302
dimethylarginine dimethylaminohydrolase (296) 296
nitric oxide (279) 279
male (266) 266
animals (252) 252
nitric-oxide synthase (239) 239
arginine - blood (201) 201
female (189) 189
endothelial dysfunction (183) 183
arginine - metabolism (177) 177
amidohydrolases - metabolism (153) 153
adma (147) 147
rats (142) 142
middle aged (129) 129
l-arginine (117) 117
arginine (116) 116
nitric oxide - metabolism (115) 115
oxidative stress (114) 114
biochemistry & molecular biology (102) 102
adult (96) 96
peripheral vascular disease (95) 95
pharmacology & pharmacy (93) 93
endothelium (92) 92
nitric oxide synthase - antagonists & inhibitors (87) 87
expression (86) 86
atherosclerosis (85) 85
dysfunction (83) 83
aged (81) 81
risk factors (80) 80
amidohydrolases - genetics (78) 78
hypertension (75) 75
endogenous inhibitor (74) 74
nitric-oxide synthesis (71) 71
plasma (66) 66
disease (65) 65
rats, sprague-dawley (64) 64
nitric oxide synthase (63) 63
mice (62) 62
nitric oxide synthase - metabolism (59) 59
nitric-oxide (58) 58
physiological aspects (58) 58
metabolism (55) 55
cardiac & cardiovascular systems (54) 54
cells, cultured (53) 53
enzymes (53) 53
mortality (51) 51
research (50) 50
endothelial-cells (48) 48
physiology (48) 48
symmetric dimethylarginine (48) 48
urology & nephrology (48) 48
pathway (47) 47
inhibitor (46) 46
case-control studies (44) 44
endocrinology & metabolism (44) 44
cell biology (43) 43
enzyme inhibitors - pharmacology (43) 43
article (42) 42
cardiovascular disease (42) 42
endothelium, vascular - metabolism (41) 41
analysis (40) 40
arginine - pharmacology (40) 40
biomarkers - blood (39) 39
cells (39) 39
endothelium, vascular - drug effects (39) 39
proteins (39) 39
risk-factor (39) 39
risk (38) 38
arginine - physiology (37) 37
asymmetric dimethylarginine adma (37) 37
coronary-artery-disease (37) 37
health aspects (37) 37
stage renal-disease (37) 37
plasma-concentrations (36) 36
inflammation (35) 35
angiogenesis (34) 34
cardiovascular-disease (34) 34
ddah (34) 34
medicine, research & experimental (34) 34
hematology (33) 33
inhibitors (33) 33
endothelial cells - drug effects (32) 32
endothelial cells - metabolism (32) 32
cardiovascular diseases (31) 31
diabetes (31) 31
synthase (31) 31
chronic kidney-disease (30) 30
nitric oxide - biosynthesis (30) 30
nitric oxide - blood (30) 30
disease models, animal (29) 29
nitric oxide synthase type iii - metabolism (29) 29
amidohydrolases - antagonists & inhibitors (28) 28
enzyme inhibitors - metabolism (28) 28
protein-arginine n-methyltransferases - metabolism (28) 28
endothelium, vascular - physiopathology (27) 27
prospective studies (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (642) 642
Japanese (5) 5
Chinese (2) 2
Turkish (2) 2
Czech (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 01/2019, Volume 842, pp. 338 - 344
The purpose of this study was to investigate the potential effect of oxymatrine in monocrotaline-induced pulmonary hypertension and its possible influence on... 
NG,NG-dimethylarginine dimethylaminohydrolase | NG,NG-dimethyl-L-arginine | Monocrotaline | Pulmonary hypertension | Protein arginine methyltransferase | Oxymatrine | dimethylarginine dimethylaminohydrolase | dimethyl-L-arginine
Journal Article
Circulation, ISSN 0009-7322, 08/2013, Volume 128, Issue 8, pp. 845 - 853
BACKGROUND—Proton pump inhibitors (PPIs) are gastric acid–suppressing agents widely prescribed for the treatment of gastroesophageal reflux disease. Recently,... 
dimethylarginine dimethylaminohydrolase | endothelium | proton pump inhibitors | nitric oxide | N,N dimethylarginine | N dimethylarginine | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | ENDOTHELIAL DYSFUNCTION | MYOCARDIAL-INFARCTION | NITRIC-OXIDE SYNTHASE | ACID SUPPRESSION | ADMA | DIMETHYLAMINOHYDROLASE DDAH | PERIPHERAL VASCULAR DISEASE | CORONARY-HEART-DISEASE | STAGE RENAL-DISEASE | ARTERY-DISEASE | Proton Pump Inhibitors - pharmacology | Humans | Esomeprazole - adverse effects | Esomeprazole - pharmacology | Endothelium, Vascular - drug effects | Male | Arginine - analogs & derivatives | Esomeprazole - therapeutic use | Cardiovascular Diseases - epidemiology | Nitric Oxide Synthase Type III - metabolism | Gastroesophageal Reflux - drug therapy | Disease Models, Animal | Amidohydrolases - metabolism | Proton Pump Inhibitors - adverse effects | Cardiovascular Diseases - metabolism | Mice, Inbred C57BL | Risk Factors | Cells, Cultured | Biomarkers - blood | Proton Pump Inhibitors - therapeutic use | Animals | Lansoprazole - adverse effects | Endothelium, Vascular - metabolism | Arginine - blood | Lansoprazole - pharmacology | Endothelium, Vascular - pathology | Mice | Vasodilation - drug effects | Lansoprazole - therapeutic use | Gastroesophageal reflux | Complications and side effects | Usage | Care and treatment | Patient outcomes | Proton pump inhibitors | Cardiovascular diseases | Drug therapy | Health aspects | Risk factors
Journal Article
Toxins, ISSN 2072-6651, 03/2017, Volume 9, Issue 3, p. 92
Asymmetric and symmetric dimethylarginine (ADMA and SDMA, respectively) are toxic, non-proteinogenic amino acids formed by post-translational modification and... 
Uremic toxins | Dimethylarginine dimethylaminohydrolase | Nitric oxide | Protein arginine methyltransferase | Asymmetric dimethylarginine | Cardiovascular disease | Symmetric dimethylarginine | Chronic kidney disease | Nonproteinogenic amino acid | Alanine-glyoxylate aminotransferase-2 | cardiovascular disease | chronic kidney disease | nitric oxide | OXIDATIVE STRESS | uremic toxins | PREVENTS HYPERTENSION | non-proteinogenic amino acid | NITRIC-OXIDE SYNTHASE | FOOD SCIENCE & TECHNOLOGY | symmetric dimethylarginine | RENAL-FUNCTION | ENDOGENOUS INHIBITOR | BLOOD-PRESSURE | protein arginine methyltransferase | dimethylarginine dimethylaminohydrolase | PLASMA-LEVELS | L-ARGININE | PRESERVES ENDOTHELIAL FUNCTION | alanine-glyoxylate aminotransferase-2 | TOXICOLOGY | asymmetric dimethylarginine | CORONARY FLOW RESERVE | Arginine - physiology | Animals | Humans | Toxins, Biological - metabolism | Toxins, Biological - physiology | Arginine - analogs & derivatives | Arginine - metabolism | Amino acids | Toxins | Illnesses | Asymmetry | chronic  kidney disease | dimethylarginine dimethylaminohydrolase | symmetric dimethylarginine | cardiovascular  disease | nitric  oxide | alanine‐glyoxylate aminotransferase‐2 | nonproteinogenic amino acid | uremic  toxins | protein arginine methyltransferase | asymmetric dimethylarginine
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 07/2011, Volume 31, Issue 7, pp. 1540 - 1546
Journal Article
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 07/2017, Volume 108, pp. 500 - 516
Reactive oxygen species have emerged as key participants in a broad range of physiological and pathophysiological processes, not least within the vascular... 
Hydrogen sulphide | Angiogenesis | NADPH oxidase 4 | Reactive oxygen species | Carbon monoxide | Nitric oxide | NITRIC-OXIDE SYNTHASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CYSTATHIONINE-GAMMA-LYASE | HEME OXYGENASE-1 GENE | ENDOGENOUS HYDROGEN-SULFIDE | SOLUBLE GUANYLYL CYCLASE | TRANSCRIPTIONAL REPRESSOR BACH1 | II-INDUCED HYPERTENSION | ENDOCRINOLOGY & METABOLISM | SMOOTH-MUSCLE-CELLS | AKT-DEPENDENT PHOSPHORYLATION | ENDOTHELIAL GROWTH-FACTOR | Animals | Reactive Oxygen Species - metabolism | Cardiovascular System - metabolism | Oxidation-Reduction | Signal Transduction | Humans | Gasotransmitters - metabolism | Gene Expression Regulation | Vascular Endothelial Growth Factor A - metabolism | Neovascularization, Physiologic | Oxidases | Heart | Phosphates | Niacinamide | Hydrogen | Physiological aspects | Neovascularization | Metalloproteins | Hydrogen sulfide | Hydrogen peroxide | Endothelial growth factors | Oxides | Superoxide | DDAHI, dimethylarginine dimethylaminohydrolase I | L-NMMA, NG-monomethyl-L-arginine | ZnPP, zinc protoporphyrin | L-NAME, NG-nitro-L-arginine-methyl ester | NAC, N-acetylcysteine | Bach-1, BTB Domain and CNC Homolog 1 (Bach1) | PTP1B, protein tyrosine phosphatase 1B | CORM-1, tricarbonyl-dichlororuthenium (II) | CORM-3, tricarbonylchloro(glucinato)ruthenium (II) | BH4, tetrahydrobiopterin | ADMA, asymmetric dimethylarginine | GPx, glutathione peroxidase | SnPPIX, tin protoporphyrin IX | HNO, nitroxyl | CORM, carbon monoxide releasing molecule | PAD, peripheral arterial disease | SDF-1, stromal cell-derived factor 1 | HRE, hypoxia response element | DDAHII, dimethylarginine dimethylaminohydrolase II | TAK1, transforming growth factor-B-activated-kinase 1 | EDRF, endothelial-derived relaxing factor (EDRF)
Journal Article